Impact of Hepatitis B Virus on Inflammatory Bowel Disease
Observational · No treatment assigned · 1 site · Tanta University
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Inflammatory Bowel Disease (IBD) and Hepatitis B Virus. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 18 and older
- Any sex
Some of the main requirements, copied from the record:
- Male or female patients older than 18 years.
- Patients with IBD are diagnosed by clinical, radiological, endoscopic, and histological criteria.
There are also 2 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 162 participants are expected to take part.
- Start date: 2024-12-01.
- Main results expected around 2025-05-30 (estimate from the record).
- 1 study site listed (1 marked recruiting) in Egypt.
Main thing being measured
- Number of patients with severe IBD measured by Truelove-Witts severity index (through study completion, an average of 6 month)
In the researchers’ words
The goal of this observational retrospective study is to assess the impact of hepatitis B virus (HBV) infection on the clinical course and outcomes of inflammatory bowel disease (IBD) in Egyptian patients. Researchers will compare the IBD extent, location, severity, and behavior between IBD patients with and without HBV infection.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Inflammatory Bowel Disease (IBD); Hepatitis B Virus |
| Lead sponsor | Tanta University |
| Enrollment | 162 (estimated) |
| Start date | 2024-12-01 |
| Primary completion (est.) | 2025-05-30 |
| First posted | 2025-03-18 |
| Last updated | 2025-03-18 |
| Official title | The Impact of Hepatitis B Virus Infection on the Clinical Course of Inflammatory Bowel Disease in Egyptian Patients |
| ClinicalTrials.gov ID | NCT06881238 |
Interventions
- History of IBD course and outcome in HBV patients (Other)
Full history taking including: * Personal history (name, age, sex, occupation, residence, and marital state). * Complaint. * Age at diagnosis of IBD. * Medication history. * History of hospital admissions and disease flares. * Disease extent, location, and behavior. (Montreal classification, Truelove-Witts severity index). * Surgical history (intestinal resection in CD patients and total proctoco…
Full eligibility criteria (from the record)
Inclusion Criteria: * Male or female patients older than 18 years. * Patients with IBD are diagnosed by clinical, radiological, endoscopic, and histological criteria. Exclusion Criteria: * Patients aged < 18 years * Unwilling to participate in our study
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| Tanta University Hospitals | Tanta, Gharbyea | Egypt | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.